The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs

Molecular Pharmacology
Laura HighRichard B Lock


Antiapoptotic Bcl-2 proteins are overexpressed in a number of cancers, including leukemias, and are frequently associated with resistance to conventional chemotherapeutic drugs. ABT-737, a Bcl-2 homology domain 3 mimetic (for structure, see Nature 435:677-681, 2005) inhibits the prosurvival function of Bcl-2, Bcl-X(L), and Bcl-w. We show that ABT-737 was effective as a single agent against a panel of pediatric acute lymphoblastic leukemia (ALL) xenografts, previously established, from patient biopsies, in immunodeficient mice. Although in vitro resistance of leukemia cell lines correlated with expression of the prosurvival protein Mcl-1, there was no relationship between Mcl-1 expression and in vivo xenograft response to ABT-737. However, expression of the pro-apoptotic protein Bim, and the extent of its association with Bcl-2, significantly correlated with in vivo ABT-737 sensitivity. ABT-737 potentiated the antileukemic effects of L-asparaginase, topotecan, vincristine, and etoposide against drug-resistant xenografts in vitro and in vivo. Finally, we show that the combination of L-asparaginase (by specifically down-regulating Mcl-1 protein levels), topotecan (by activating p53 via DNA damage), and ABT-737 (by inhibiting antia...Continue Reading


Apr 16, 1998·Journal of the National Cancer Institute·W C ZamboniPeter J Houghton
Sep 12, 1998·Science·J M Adams, Suzanne Cory
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Jan 4, 2001·Cell·D C S Huang, Andreas Strasser
Apr 2, 2003·Molecular Cell·Motohiro MiharaUte M Moll
Aug 28, 2003·Archives of Biochemistry and Biophysics·Daniel Iglesias-SerretJosé M López
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·William C Rose, Robert Wild
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Jan 13, 2006·The New England Journal of Medicine·Ching-Hon Pui, William E Evans
Mar 8, 2006·Cancer Chemotherapy and Pharmacology·Bo YangQiaojun He
Jan 27, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Suzanne TrudelXiao Yan Wen
Apr 6, 2007·Cancer Research·Yun Dai, Steven Grant
Oct 9, 2007·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Lin ZhangJian Yu
Dec 7, 2007·Blood·Victoria Del Gaizo MooreAnthony Letai
Dec 19, 2007·Pediatric Blood & Cancer·Richard B LockMalcolm A Smith
Sep 2, 2008·The Lancet Oncology·L Charles BaileyNancy J Bunin
Sep 23, 2008·Cell Death and Differentiation·M VoglerG M Cohen
Nov 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kylie D MasonAndrew W Roberts
Jan 17, 2009·Cell Death and Differentiation·Ewa M MichalakClare L Scott


Oct 6, 2011·Pediatric Surgery International·Justus LieberSorin Armeanu-Ebinger
Oct 18, 2011·Apoptosis : an International Journal on Programmed Cell Death·Katrin E TagschererWilfried Roth
Dec 17, 2010·Investigational New Drugs·Michael DickinsonH Miles Prince
Apr 16, 2011·Leukemia·L S SteelmanJames A McCubrey
Jun 8, 2011·Antioxidants & Redox Signaling·Simone Fulda, Guido Kroemer
Nov 25, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J G van OosterwijkJ V M G Bovée
Jul 14, 2012·BMC Cancer·Jun Sakakibara-KonishiMasaharu Nishimura
Jun 26, 2014·European Journal of Medical Research·Dongmei HeYangqiu Li
Nov 23, 2012·Pharmacogenomics·Soizic GuihardMeyling H Cheok
Apr 7, 2011·Cellular Oncology (Dordrecht)·Daniëlle A E RaatsOnno Kranenburg
Feb 22, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hernan CarolRichard B Lock
Sep 8, 2012·Cellular and Molecular Life Sciences : CMLS·Giovanni MonacoGeert Bultynck
Mar 29, 2011·Apoptosis : an International Journal on Programmed Cell Death·Joanna SkommerSubhadip Raychaudhuri
Jan 25, 2013·Apoptosis : an International Journal on Programmed Cell Death·Karin SimoninLaurent Poulain
Feb 18, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Małgorzata Opydo-Chanek, Lidia Mazur
Feb 11, 2014·Critical Reviews in Oncology/hematology·Khurum H KhanL Rhoda Molife
Mar 19, 2013·Journal of Healthcare Engineering·Subhadip Raychaudhuri, Somkanya C Das
Jul 20, 2011·Cancer Letters·Nathalie DroinEric Solary
Nov 3, 2010·Cancer Letters·Simone Fulda
Aug 18, 2012·Journal of Molecular Signaling·Vasileios A StamelosAlan Richardson
Nov 22, 2015·Journal of Hematology & Oncology·Shundong CangDelong Liu
Jan 28, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Hadi KaramiEbrahim Sakhinia
May 24, 2012·Journal of Molecular Biology·Joe DeBartoloAmy E Keating
Dec 27, 2011·Expert Opinion on Therapeutic Patents·Naval BajwaZaneta Nikolovska-Coleska
Apr 29, 2015·Mutation Research·Tanmay M ShekharChristine J Hawkins
Mar 1, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Fieke LamersJan J Molenaar
Dec 21, 2013·Experimental Cell Research·Justus LieberSorin Armeanu-Ebinger
Sep 10, 2016·Blood·Naval Daver, Marina Konopleva
Oct 18, 2016·Expert Opinion on Therapeutic Patents·Lijia Chen, Steven Fletcher
Dec 1, 2017·Antioxidants & Redox Signaling·Stephen Jun Fei ChongShazib Pervaiz
Jul 2, 2011·Journal of Leukocyte Biology·Kate E LawlorIan P Wicks
Aug 4, 2010·Pediatric Blood & Cancer·Justus LieberSorin Armeanu-Ebinger
Feb 27, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Hadi KaramiEbrahim Sakhinia
Oct 28, 2019·Cancers·Zhang'e ChooZhi Xiong Chen
Nov 19, 2010·Expert Review of Hematology·Jean-Pierre Bourquin, Beat Bornhauser
Sep 2, 2016·Science Translational Medicine·Jessica LeonardBill H Chang
Apr 14, 2016·Biochemical Society Transactions·Hannah Karlsson
Jul 31, 2012·Pharmazie in unserer Zeit·Martin Stanulla, Jean-Pierre Bourquin
Jul 12, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Santi SuryaniRichard B Lock
Dec 15, 2020·Journal of Oncology·Omar Ugarte-AlvarezRosendo Luria-Pérez
May 22, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sara SamuelJohn Hiscott
May 5, 2021·Biochimica Et Biophysica Acta. Molecular Cell Research·Gabriel PradoRichard L Bennett

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.